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Qualitative research: Is this a missing link to control
tuberculosis in Saudi Arabia?Tuberculosis (TB) is a major public health problem world-
wide, with 9 million newly reported cases and 1.4 million
deaths annually [1]. TB can be cured with a 6-month standard
anti-TB drug therapy. However, many patients fail to complete
the treatment for various reasons – which include drugs have
unpleasant side-effects, treatment is complicated, patients
are not aware of the consequences of the discontinuation of
medication, and patients feel better after several weeks of
treatment. Poor adherence to treatment is common despite
various interventions aimed to improve treatment completion
and outcome. Poor compliance leads the patient to remain
infectious for longer and most likely suffer a relapse and die
in the future. To minimize all the above said issues, The World
Health Organization (WHO) recommends the directly observed
treatment, short course (DOTS), strategy which enables the pa-
tient to be monitored during the treatment on a daily basis by a
health careworker [2]. However, defiance to such strategies still
remains high among patients, particularly in developing coun-
tries [3]. The reasons for such defiance are not really under-
stood in many settings, including Saudi Arabia.
In Saudi Arabia the annual TB infection rate is moderate
(24 cases/100,000 population) [1]. Indeed, the treatment out-
come has never reached the 85% target set by WHO, despite
the introduction of DOTS in the early 1990s [4]. It is presumed
that there may be certain valid reasons causing such failures
in the country. These reasons include and are not limited to:
1. Almost 48% of total TB patients are expatriates [5]. The
majority of those expatriates are not well educated and
may not be aware of the consequences of the failure to
complete the medications.
2. Large proportions of expatriates are staying illegally in the
country and fear deportation. Thus, they might run away
from hospitals shortly after they feel better.
3. The majority of the expatriates are living in the country
without their family and lack a long-term support.
4. The social stigma about the disease still exists in the
society.
5. Fear of the long-term hospitalization.
In contrary to these reasons, previous international meta-
ethnography studies showed several factors for
non-adherence to therapy, such as health services factors
(organization of treatment and care), social context (family,community and household influences), and financial and
physical burden of treatment [6]. Themes should be con-
structed out of these factors to answer the question why pa-
tients do not adhere to medication intake? As an example in
Saudi Arabia, the burden of treatment cost does not play a role
because the government bears the cost for both citizens and
expatriates. At this stage, it is not clear whether these factors
are really playing a role or additional unknown factors are also
involved in this problem. Indeed, if the factors which make the
patient drive away from proper adherence are not traced, the
outcome of the current TB control strategies will be limited.
Therefore, qualitative research is needed to gain an insight into
the facts as to why patients do not comply with treatment
policies.
In conclusion, it is believed that the qualitative research
might be the missing link in the efforts to control the disease.
Thus in this letter, the decision makers are invited to take
immediate action to conduct a qualitative research to find
the root causes of treatment non-compliance in Saudi Arabia.
Such research should be carried out in alliance with a team of
sociologists, anthropologists and TB care providers.
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